• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病住院患者静脉血栓栓塞症发生率的增加:一项全国性分析。

Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.

机构信息

Division of Gastroenterology, NYU Grossman School of Medicine, New York, New York, USA.

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Aliment Pharmacol Ther. 2022 Oct;56(7):1157-1167. doi: 10.1111/apt.17162. Epub 2022 Jul 25.

DOI:10.1111/apt.17162
PMID:35879231
Abstract

BACKGROUND

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited.

AIMS

To assess national trends in VTE-associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events METHODS: Using the U.S. Nationwide Inpatient Sample from 2000-2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs).

RESULTS

Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p < 0.001), and remained significant when stratified by ulcerative colitis (UC) and Crohn's disease as well as by deep vein thrombosis and pulmonary embolism. On multivariable analysis, increasing age, male sex, UC (aOR: 1.30, 95%CI 1.26, 1.33), identifying as non-Hispanic Black, and chronic corticosteroid use (aOR: 1.22, 95%CI 1.16, 1.29) were associated with an increased risk of a VTE-associated hospitalisation.

CONCLUSION

Rates of VTE-associated hospitalisations are increasing among patients with IBD. Continued efforts need to be placed on education and risk reduction.

摘要

背景

静脉血栓栓塞症(VTE)是炎症性肠病(IBD)患者发病率和死亡率的重要原因。然而,关于全国趋势的数据仍然有限。

目的

评估 IBD 患者中与 VTE 相关的住院治疗的全国趋势,以及这些事件的危险因素和死亡率。

方法

使用 2000 年至 2018 年美国全国住院患者样本,使用国家癌症研究所的 Joinpoint 回归程序评估 VTE 的时间趋势,估计值表示平均年度百分比变化(AAPC)和 95%置信区间(CI)。

结果

在 2000 年至 2018 年间,有 4859728 名 IBD 患者住院治疗,其中 128236 例(2.6%)患有 VTE,6352 例与死亡相关。IBD 住院患者中 VTE 的发生率从 192 例增加到 295 例每 10000 例住院治疗(AAPC 2.4%,95%CI 1.4%,3.4%,p<0.001),当按溃疡性结肠炎(UC)和克罗恩病以及深静脉血栓形成和肺栓塞分层时仍然显著。多变量分析显示,年龄增长、男性、UC(OR:1.30,95%CI 1.26,1.33)、非西班牙裔黑人、长期使用皮质类固醇(OR:1.22,95%CI 1.16,1.29)与 VTE 相关的住院风险增加相关。

结论

IBD 患者中与 VTE 相关的住院治疗率正在上升。需要继续努力进行教育和降低风险。

相似文献

1
Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.炎症性肠病住院患者静脉血栓栓塞症发生率的增加:一项全国性分析。
Aliment Pharmacol Ther. 2022 Oct;56(7):1157-1167. doi: 10.1111/apt.17162. Epub 2022 Jul 25.
2
Inflammatory bowel disease and pulmonary embolism: a nationwide perspective.炎症性肠病与肺栓塞:全国视角。
Eur J Gastroenterol Hepatol. 2024 Dec 1;36(12):1410-1418. doi: 10.1097/MEG.0000000000002851. Epub 2024 Sep 12.
3
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.中重度溃疡性结肠炎和克罗恩病对性活动的影响:来自炎症性肠病经历的沟通需求与特征(CONFIDE)调查的美国和欧洲患者观点
Curr Med Res Opin. 2025 Jul 17:1-14. doi: 10.1080/03007995.2025.2530736.
4
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
5
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
6
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
7
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
8
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
9
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.用于治疗炎症性肠病风湿性表现的选择性环氧化酶2抑制剂的耐受性
Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2.
10
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.

引用本文的文献

1
Clots in colitis: Thromboembolism and beyond.结肠炎中的血栓形成:血栓栓塞及其他相关问题。
World J Clin Cases. 2025 Sep 16;13(26):102957. doi: 10.12998/wjcc.v13.i26.102957.
2
Risk of malnutrition increases in the year prior to surgery among patients with inflammatory bowel disease.炎症性肠病患者在手术前一年营养不良风险增加。
Therap Adv Gastroenterol. 2025 Aug 19;18:17562848251365036. doi: 10.1177/17562848251365036. eCollection 2025.
3
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitis.

本文引用的文献

1
Trends in Venous Thromboembolism and Associated Risk Factors During Delivery Hospitalizations From 2000 to 2018.2000 年至 2018 年分娩住院期间静脉血栓栓塞症及相关危险因素的变化趋势。
Obstet Gynecol. 2022 Feb 1;139(2):223-234. doi: 10.1097/AOG.0000000000004648.
2
Comparison of strategies for adherence to venous thromboembolism prophylaxis in high-risk surgical patients: a before and after intervention study.比较高危手术患者预防静脉血栓栓塞策略的依从性:一项干预前后研究。
BMJ Open Qual. 2021 Oct;10(4). doi: 10.1136/bmjoq-2021-001583.
3
Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.
克罗恩病和溃疡性结肠炎肠外表现及相关自身免疫性疾病的网络分析
NPJ Digit Med. 2025 Apr 15;8(1):209. doi: 10.1038/s41746-025-01504-6.
4
Uncovering novel therapeutic clues for hypercoagulable active ulcerative colitis: novel findings from old data.揭示高凝性活动性溃疡性结肠炎的新治疗线索:旧数据中的新发现
Gastroenterol Rep (Oxf). 2024 Dec 28;12:goae105. doi: 10.1093/gastro/goae105. eCollection 2024.
5
All-cause mortality of hospitalized inflammatory bowel disease patients: a multicenter study from Iran.住院炎症性肠病患者的全因死亡率:一项来自伊朗的多中心研究。
Gastroenterol Hepatol Bed Bench. 2024;17(3):279-287. doi: 10.22037/ghfbb.v17i3.2962.
6
Risk of heart failure in inflammatory bowel disease: a Swedish population-based study.炎症性肠病患者发生心力衰竭的风险:一项瑞典基于人群的研究。
Eur Heart J. 2024 Jul 21;45(28):2493-2504. doi: 10.1093/eurheartj/ehae338.
7
Portal vein thrombosis as extraintestinal complications of Crohn's disease: a case report and review of literature.门静脉血栓形成作为克罗恩病的肠外并发症:病例报告及文献复习。
J Med Case Rep. 2024 May 14;18(1):246. doi: 10.1186/s13256-024-04560-w.
8
Subtypes of Venous Thromboembolism in Inflammatory Bowel Disease: A Nationwide Assessment.炎症性肠病中静脉血栓栓塞的亚型:一项全国性评估。
Clin Res Clin Trials. 2024;9(3). Epub 2024 Mar 5.
9
Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure.慢性阻塞性肺疾病或心力衰竭内科住院患者使用依诺肝素或普通肝素进行血栓预防的有效性、安全性及成本
J Health Econ Outcomes Res. 2024 Feb 20;11(1):44-56. doi: 10.36469/001c.92408. eCollection 2024.
10
Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.炎症性肠病的心血管表现及其潜在发病机制。
Am J Physiol Regul Integr Comp Physiol. 2023 Aug 1;325(2):R193-R211. doi: 10.1152/ajpregu.00300.2022. Epub 2023 Jun 19.
住院与门诊急性静脉血栓栓塞症管理:2011 年至 2018 年的趋势和急性后医疗保健利用情况。
J Am Heart Assoc. 2021 Oct 19;10(20):e020428. doi: 10.1161/JAHA.120.020428. Epub 2021 Oct 8.
4
Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.炎症性肠病患者住院后静脉血栓栓塞预防的成本效益。
Inflamm Bowel Dis. 2022 Aug 1;28(8):1169-1176. doi: 10.1093/ibd/izab246.
5
Delivery risks and outcomes associated with grand multiparity.与多胎妊娠相关的分娩风险和结局。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7708-7716. doi: 10.1080/14767058.2021.1960972. Epub 2021 Sep 1.
6
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.国际炎症性肠病患者静脉和动脉血栓栓塞事件预防共识。
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):857-873. doi: 10.1038/s41575-021-00492-8. Epub 2021 Aug 27.
7
Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.炎症性肠病患者的结直肠狭窄并不能独立预测结直肠肿瘤。
Inflamm Bowel Dis. 2022 Jun 3;28(6):855-861. doi: 10.1093/ibd/izab177.
8
Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.炎症性肠病中静脉血栓栓塞的危险因素:一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Jun 28;8:693927. doi: 10.3389/fmed.2021.693927. eCollection 2021.
9
Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes.为溃疡性结肠炎住院患者提供实践指南可改善患者报告的结局。
J Can Assoc Gastroenterol. 2020 Jun 9;4(3):131-136. doi: 10.1093/jcag/gwaa019. eCollection 2021 Jun.
10
Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.炎症性肠病患者产后病情恶化住院的风险在六个月后仍持续存在。
Dig Dis Sci. 2022 Sep;67(9):4278-4286. doi: 10.1007/s10620-021-06999-z. Epub 2021 May 1.